Exercise and Pioglitazone for HIV-Metabolic Syndromes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions

HIV InfectionsType 2 DiabetesObesityHIVAIDSCardiovascular DiseaseLipodystrophy

Interventions

DRUG

Pioglitazone

Oral 30mg/day for 16 weeks

BEHAVIORAL

Exercise training

Supervised aerobic and resistance exercise training (1.5hrs/day x 3 days/wk) for 16 weeks

Trial Locations (1)

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00639457 - Exercise and Pioglitazone for HIV-Metabolic Syndromes | Biotech Hunter | Biotech Hunter